BCIP Life Sciences Associates, LP's Form 4 filing
Solid Biosciences Inc. (SLDB) · filed Feb 21, 2025
- Accession no.
- 0000950170-25-025011
- Filed
- Feb 21, 2025, 5:48 PM ET
- Trade date
- Feb 19, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $4.03M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BCIP Life Sciences Associates, LPCIK 0001702921 | 10% Owner |
| Bain Capital Life Sciences Partners, LPCIK 0001703030 | 10% Owner |
| Bain Capital Life Sciences Investors, LLCCIK 0001703031 | 10% Owner |
| BCLS SB Investco, LPCIK 0001728056 | 10% Owner |
| Bain Capital Life Sciences Fund II, L.P.CIK 0001773187 | 10% Owner |
| Bain Capital Life Sciences Investors II, LLCCIK 0001796155 | 10% Owner |
| BCLS II Equity Opportunities, LPCIK 0001814474 | 10% Owner |
| BCLS II Investco, LPCIK 0001818893 | 10% Owner |
| BCLS II Investco (GP), LLCCIK 0001819101 | 10% Owner |
| BCLS II Equity Opportunities GP, LLCCIK 0002008174 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Common Stock | PPurchaseAcquired | +1,000,000 | $4.03 | +$4,030,000 | 5,034,582 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Common Stock | PPurchaseAcquired | +6,444,170 | $4.03 | +$25,963,560.93 | 6,444,170 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.